文献速递妇产影像US

流产後妊娠相关子宫肌层血供增强的自然转归

Natural history of pregnancy-related enhanced myometrial vascularity following miscarriage.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

前瞻性队列研究纳入伦敦教学医院2015年6月至2018年6月早孕评估单元中早孕期流产后经阴道超声发现子宫肌层血供增强(EMV)的连续患者,EMV诊断依据彩色多普勒主观识别血管团且收缩期峰值流速(PSV)≥20 cm/s。流产後EMV发生率为1.52%(40/2627),所有病例均伴妊娠物残留(RPOC)超声证据;31例初始选择期待管理,其中18例自行消退,8例因患者选择后续行手术清除,无期待管理病例需急诊干预;9例首选手术清除,手术失血量20–300 mL,无患者需输血或栓塞。

要点

  • 早孕期流产后EMV发生率1.52%(40/2627),所有病例均伴超声可见的妊娠物残留(RPOC)。
  • EMV诊断依据彩色多普勒主观识别血管团且PSV≥20 cm/s,中位PSV为47(范围20–148)cm/s。
  • 期待管理组18例成功消退、无急诊干预,但消退时间较长(平均48天,范围21–84天)。

核心结论

  • 本研究提示EMV是流产后不常见的发现,与RPOC存在相关;在本队列中期待管理是安全选项,出血轻微,但消退时间较长;选择手术者最大失血量300 mL,无患者需输血或栓塞。

研究设计与样本

  • 前瞻性队列研究,2015年6月至2018年6月在伦敦一家教学医院早孕评估单元连续纳入早孕期流产后经阴道超声发现EMV的患者,共40例;EMV诊断依据彩色多普勒主观识别血管团且PSV≥20 cm/s;每14天复查超声随访;参考标准为临床结局及手术标本病理。

关键影像表现/征象

  • 所有EMV病例均伴超声可见的妊娠物残留(RPOC),平均尺寸22×20×20 mm。
  • EMV血管团中位PSV为47(范围20–148)cm/s。
  • 手术清除病例估计失血量范围为20–300 mL。

诊断标准与关键数值

  • EMV诊断标准:彩色多普勒超声主观识别子宫肌层血管团,且血管团内PSV≥20 cm/s。
  • 研究期间早孕期胎儿丢失共2627例,诊断EMV 40例,流产后EMV发生率为1.52%。

临床应用与阅片要点

  • 早孕期流产后发现子宫肌层丰富血流时,应测量PSV并以≥20 cm/s作为EMV诊断参考阈值。
  • EMV常伴RPOC,报告时应描述RPOC的存在及尺寸。
  • 本研究中期待管理无急诊干预病例,但消退时间较长;手术清除失血量20–300 mL,无输血或栓塞病例。

局限性

  • 本研究为单中心前瞻性队列,样本量为40例。
  • 31例期待管理患者中5例失访。
  • 作者指出本研究提示EMV是流产后不常见发现,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Our primary aim was to report the incidence of enhanced myometrial vascularity (EMV) in consecutive women attending our early pregnancy assessment unit, following first-trimester miscarriage. We aimed further to evaluate the clinical presentation and complications associated with expectant and surgical management of EMV in these women.

METHODS: This was a prospective cohort study conducted in a London teaching hospital between June 2015 and June 2018, including consecutive patients with an observation of EMV on transvaginal ultrasonography following first-trimester miscarriage. The diagnosis was made following the subjective identification of EMV using color Doppler ultrasonography and a peak systolic velocity (PSV) ≥ 20 cm/s within the collection of vessels. Women were followed up with repeat scans every 14 days. Management was expectant unless intervention was indicated because of excessive or prolonged bleeding, persistent presence of retained tissue in the endometrial cavity or patient choice. The final clinical outcome was recorded. Time to resolution of EMV was defined as the interval from detection of EMV until resolution.

RESULTS: During the study period, there were 2627 first-trimester fetal losses in the department and, of these, 40 patients were diagnosed with EMV, hence the incidence of EMV following miscarriage was 1.52%. All cases were associated with ultrasound evidence of retained products of conception (RPOC) at presentation (mean dimensions, 22 × 20 × 20 mm). Thirty-one patients opted initially for expectant management, of which 18 had successful resolution without intervention, five were lost to follow-up and eight subsequently had surgical evacuation due to patient choice. No expectantly managed case required emergency intervention. Nine patients chose surgical evacuation as primary treatment. No significant correlation was seen between PSV within the EMV at presentation and blood loss at surgery. Median PSV was 47 (range, 20-148) cm/s. The estimated blood loss in all cases managed surgically ranged from 20-300 mL. Presence of RPOC was confirmed in all specimens that were sent for analysis following surgery. For cases successfully managed expectantly, the mean time to resolution was 48 (range, 21-84) days. In the nine cases managed surgically from the beginning, the mean time to resolution of EMV was 10.6 (range, 3-29) days.

CONCLUSIONS: This study suggests that EMV is an uncommon finding following miscarriage and is associated with the presence of RPOC. Expectant management was a safe option in our cohort, with minimal bleeding, although it was associated with protracted time to resolution. In patients who opted for surgery, the maximum blood loss was 300 mL and no patient required blood transfusion or embolization. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Grewal K, Al-Memar M, Fourie H, et al. Natural history of pregnancy-related enhanced myometrial vascularity following miscarriage. Ultrasound Obstet Gynecol. 2020. PMID: 31503383. doi:10.1002/uog.21872

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。